The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer#39;s disease, attention deficient hyperactivity disorder, Huntington#39;s disease, Parkinson#39;s and schizophrenia, it added.Suven Life gets product patents in Eurasia, Europe, South Korea and Sri Lanka
The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer#39;s disease, attention deficient hyperactivity disorder, Huntington#39;s disease, Parkinson#39;s and schizophrenia, it added.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The bank plans to raise up to Rs 500 crore by issue of equity shares to qualified institutional buyers through qualified institutional plac...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment